Metagenomic Sequencing For Veterinary Microbiome Diagnostics
Metagenomic sequencing in veterinary microbiome diagnostics examines the genetic material present in a biological sample, usually faeces, without requiring organisms to be grown in culture. Instead of targeting one suspected bacterium, shotgun sequencing can survey bacteria, archaea, fungi, viruses and functional genes within the microbial community. This broader view is especially relevant to chronic enteropathies, diarrhoea, dysbiosis and antimicrobial stewardship in dogs and cats.
For Australian veterinary teams, the technology sits between research and routine clinical practice. A metropolitan referral hospital in Sydney or Melbourne may have access to specialist pathology services, while a mixed practice in regional Queensland or Western Australia may need to courier specimens interstate. Understanding what the assay measures, and what it cannot prove, helps clinicians interpret results with appropriate caution.
What Metagenomic Sequencing Reveals
Traditional culture detects organisms that grow under selected laboratory conditions. Targeted PCR is faster for a defined pathogen or virulence gene, while 16S rRNA sequencing provides a useful profile of bacterial taxa. Shotgun metagenomics goes further by sequencing DNA fragments across the sample, allowing species-level classification in some cases and offering clues about metabolic pathways, toxin production and antimicrobial resistance genes.
That breadth can reveal community changes that are missed by single-organism testing. A dog with chronic enteropathy may show reduced microbial diversity, altered short-chain fatty acid pathways or an expansion of taxa associated with inflammation. Yet a DNA sequence is evidence of genetic material, not necessarily active infection. It may represent dead organisms, transient colonisation or a normal component of the animal’s intestinal ecosystem.
Where It Adds Clinical Value
The strongest application is often comparative rather than absolute. A faecal profile collected before and after dietary management, probiotic use or treatment can help researchers investigate microbiome shifts. In clinical work, however, the result should be interpreted alongside history, physical examination, bloodwork, imaging, endoscopy and histopathology. A dysbiosis index or microbial signature is not a substitute for diagnosing inflammatory bowel disease, exocrine pancreatic insufficiency or intestinal neoplasia.
Metagenomics may also support investigation of complex cases involving recurrent diarrhoea, suspected antimicrobial resistance or unusual organisms. For example, targeted reading on Clostridium perfringens resource can help place a bacterial finding in the wider context of canine haemorrhagic gastroenteritis rather than treating detection alone as proof of causation.
How Results Can Mislead
Sample quality is a major determinant of usefulness. Collection from a freshly voided stool sample is generally preferable, with prompt cooling or freezing according to the laboratory’s instructions. Delays, repeated freeze–thaw cycles, environmental exposure and contamination from collection containers can alter the microbial profile. Rectal swabs contain less material and may not represent the same microbial community as a full faecal sample.
Laboratory and analytical choices also affect the report. Host DNA can overwhelm microbial reads, and low-biomass samples are particularly vulnerable to reagent contamination. Reference databases differ in completeness, taxonomic assignments may be revised, and bioinformatics pipelines can produce different abundance estimates from the same raw data. Results should therefore be assessed with information about controls, sequencing depth, quality thresholds and the reporting laboratory’s validation process.
| Diagnostic approach | Main strength | Common limitation | Useful clinical role |
|---|---|---|---|
| Culture | Can support isolation and susceptibility testing | Favours organisms that grow under selected conditions | Suspected bacterial infection and antimicrobial decisions |
| Targeted PCR | Rapid and sensitive for defined targets | Cannot survey the whole community | Confirming a pathogen, toxin or resistance gene |
| 16S rRNA sequencing | Cost-effective bacterial community profiling | Limited species and functional resolution | Research and broad dysbiosis assessment |
| Shotgun metagenomics | Wide taxonomic and functional coverage | Higher cost, complex interpretation and possible host-DNA interference | Discovery, longitudinal studies and selected complex cases |
Building A Reliable Diagnostic Workflow
A useful workflow begins before sequencing. The clinician should document diet, recent antimicrobials, corticosteroids, acid-suppressing drugs, hospitalisation, travel, parasite control and the timing of clinical signs. Faecal consistency, collection time and storage conditions should accompany the sample. Comparing samples collected under standardised conditions is more informative than comparing poorly documented specimens.
The laboratory report should identify the assay type, extraction method, sequencing platform, quality controls, database version and thresholds used for classification. It should distinguish relative abundance from absolute load, since an increase in one taxon can make others appear proportionally lower without true depletion. If a result could change therapy, confirmatory PCR, culture, susceptibility testing or repeat sampling may be warranted.
Using Findings In Australian Practice
In Australia, the practical question is often whether a result will change management quickly enough to justify its cost. A Brisbane emergency hospital investigating acute haemorrhagic diarrhoea may prioritise rapid targeted testing, whereas a university-linked research project in Melbourne may use deep shotgun sequencing to study chronic disease mechanisms. For a rural clinic serving farms and companion animals, courier timing and cold-chain reliability can matter as much as the analytical method.
Veterinary teams should also account for local referral pathways and client expectations. Pet owners may ask for “the most comprehensive test”, but a broad microbiome profile can be difficult to explain when the finding is associative rather than diagnostic. Clear communication about uncertainty, turnaround times and follow-up testing is essential, particularly where out-of-pocket spending is common and pet insurance policies vary.
Educational material from the ActivBiome learning hub offers webinars and resources for professionals exploring gut microbiome science, while research on kidney disease findings illustrates how microbiome signatures may intersect with conditions outside primary gastrointestinal disease. Used carefully, metagenomic sequencing can extend clinical understanding; used without context, it can turn a complex ecosystem into an overconfident laboratory label.